Inactivating AKT2 variant leads to severe insulin resistance and lipodystrophy (George et al. 2004), whereas activating AKT2 variants lead to hypoglycemia (Hussain et al. 2011, Arya et al. 2014). This evidence concerns the gene AKT2 and lipodystrophy.